Boundless Bio, Inc. (BOLD) SEC Filings & Financial Intelligence
Boundless Bio, Inc. (BOLD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BOLD
CIK: 1782303
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerGerald Schemidt
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-05 | 2026-11-03 | 4 Filing | 0001178579-26-000023 | View SEC Doc Filr Page |
| EFFECT | 2026-11-03 | — | EFFECT Filing | 9999999995-26-003420 | View SEC Doc Filr Page |
| 424B3 | 2026-11-03 | — | 424B3 | 0001193125-26-445503 | View SEC Doc Filr Page |
| S-4/A | 2026-11-02 | — | S-4/A | 0001193125-26-442255 | View SEC Doc Filr Page |
| 4 | 2026-10-29 | 2026-10-27 | 4 Filing | 0001178579-26-000022 | View SEC Doc Filr Page |
| 425 | 2026-10-26 | — | 425 | 0001193125-26-432157 | View SEC Doc Filr Page |
| 4 | 2026-10-26 | 2026-10-22 | 4 Filing | 0001178579-26-000020 | View SEC Doc Filr Page |
| 425 | 2026-10-26 | — | 425 | 0001193125-26-431041 | View SEC Doc Filr Page |
| 4 | 2026-10-20 | 2026-10-16 | 4 Filing | 0001178579-26-000019 | View SEC Doc Filr Page |
| S-4 | 2026-10-08 | — | S-4 | 0001193125-26-417903 | View SEC Doc Filr Page |
| DRS | 2026-08-31 | — | DRS Filing | 0001193125-26-375323 | View SEC Doc Filr Page |
| 425 | 2026-08-28 | — | 425 | 0001193125-26-374789 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-28 | 8-K | 0001193125-26-374787 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-26 | 4 Filing | 0001178579-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-27 | — | SCHEDULE 13G Filing | 0001193125-26-371863 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097418 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097051 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001193125-26-339093 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-17 | 4 Filing | 0001178579-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | 4 Filing | 0001178579-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | 4 Filing | 0001178579-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-06 | 4 Filing | 0001178579-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000622 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000621 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0001178579-26-000009 | View SEC Doc Filr Page |